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Background: Low-level laser therapy is one of the adjunct treatments of choice with exercise therapy for shoulder
rehabilitation in physiotherapy clinical practices. Although previous reviews have found little use of low-level laser
therapy, there are recent trials whose findings are yet to be systematically reviewed.
Methods: We plan to do a systematic review to assess the effects of low-level laser therapy with exercise and
exercise alone in participants who are 18 years and above, with a clinical or radiological diagnosis of various shoulder
pathologies. We will search CENTRAL, MEDLINE, CINAHL, PEDro, Science Direct, Scopus and Physiotherapy Choices
regardless of publication status. We will hand search for subject-specific journals (PhotoMedicine and Laser Surgery,
Lasers in Surgery and Medicine and Journals of Lasers in Medical Science) and conference proceedings of World
Association for Laser Therapy. Two review authors will independently screen, select studies, extract data and assess the
risk of bias based on a priori criteria. Disagreements between review authors will be resolved either through discussion
or consultation with a third review author. If there are at least two clinically homogeneous studies, we will perform
meta-analysis.
Discussion: The findings will shed more light on the benefit of low-level laser therapy as an adjunct treatment to
exercise in the management of shoulder disorders. The findings may also inform decision makers in the review and
development of guidelines for shoulder rehabilitation in physiotherapy practices.
Systematic review registration: PROSPERO CRD42014013691
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Various shoulder disorders such as sub-acromial im-
pingement, rotator-cuff tear and frozen shoulder are im-
portant complaints of shoulder pain and disability and
commonest referrals to physiotherapy clinics [1]. Shoul-
der complaints presenting as painful shoulder, muscular
weakness, diminished range of motion and restricted
daily activities are reasons for outpatient visits in physio-
therapy clinics [1-5]. Physiotherapy is considered the
first line of conservative management and inevitably an
adjunct treatment for post-surgical interventions [6]. Of* Correspondence: awotidebe.adedapo@gmail.com
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unless otherwise stated.all the shoulder complaints treated by the general practi-
tioners (GP) in primary care, between 10% and 30% are
referred for physical therapy [1,7].
In a routine physiotherapy clinic, management of vari-
ous musculoskeletal shoulder disorders is multifaceted
and treatment includes a broad spectrum of physiothera-
peutic options such as progressive strengthening exercises,
strapping, electrotherapy, low-grade joint manipulation/
mobilisation therapy, acupuncture, advice and education
[7,8]. However, compared to other treatment options, ex-
ercise therapy which includes joint and soft-tissue mobil-
isation, stretching/flexibility, range of motion and gradual
strengthening exercises is the mainstay of rehabilitation
protocol for shoulder pain [8,9]. In addition to exercise
therapy, the use of low-level laser therapy (LLLT) is
also evident among physiotherapists in a wide range oftral. This is an Open Access article distributed under the terms of the Creative
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LLLT is non-thermal and is considered safe; however,
its use is contraindicated in part or entirely in patients
with malignant tumours, epilepsy, light hypersensitivity,
applications over thyroid gland, thrombotic deep vein
thrombotic area and treatment around developing
foetus in pregnant women [12,13]. Similarly, it is con-
traindicated in patients using steroids because it hin-
ders the effect of laser treatment [14].
The LLLT, also known as phototherapy, is a non-
invasive application of non-thermal and low-powered
laser light of single wavelength of classes IIIa and IIIb
[15]. The protocol for laser treatment in musculoskeletal
disorders is associated with better performance in wave-
lengths of between 632 and 1,064 nm and laser power
output of less than 5 mW (class IIIa) or less than
500 mW (class IIIb) [12]. The LLLT is typically adminis-
tered in a routine therapeutic treatment as either sta-
tionary in skin contact or stationary with distance from
skin over a maximum of ten trigger or painful points for
90 s at 2,000 Hz [16], 150 s at 3,500 Hz [17], or 5 min at
1,000 Hz [18] per painful point.
Mechanism of action and clinical effect of low-level laser
therapy was described by Moshkovska and Mayberry [13]
and illustrated in Table 1. All forms of LLLT are used on
the site of pathology (for example tendon, joint capsule,
cartilage, muscle) or nerve supplying area on acupunc-
ture or trigger points. There was evidence that LLLT
in vitro studies facilitated the stimulation of fibroblasts
and collagen synthesis in connective tissue repair
[19,20]. Evidence exists that LLLT, in addition to connect-
ive tissue repair, reduces inflammation and modulates pain
[10] through reduction of prostaglandin E2 (PGE2) recep-
tor concentration and inhibition of cyclooxygenase-2
(COX-2) [21,22]. Findings from animal study showed that
low-power laser radiation (780 nm) on injured rat sciatic
nerve accelerates peripheral nerve regeneration by enhan-
cing axonal growth [23].Table 1 Mechanism of action of low-level laser therapy [13]
Types of effect Mechanisms
Anti-inflammatory effect Activation of microcirculation
Prostaglandin level changes
Equalisation of osmotic pressure
Stabilisation of lipid peroxidation Reactivation of superoxide dysmuta
Analgesic Activation of neuron metabolism a
Reparation of wound stimulation ATP accumulation
Activation of cellular metabolism
Increase proliferation of fibroblasts
Immune response stimulation Increase proliferation of immune m
Accelerate maturation of immune m
Reflexogenic effect Excitation of nerve centresIn recent years, low-level laser therapy is increasingly
being combined with exercise than exercise alone for
management of pain and functions in various rehabilita-
tion of musculoskeletal injuries [24-26]. In spite of the
drive for evidence-based practice in physiotherapy, recom-
mending for widespread use of LLLT, especially in
shoulder rehabilitation, is ambivalent because there was
insufficient evidence to determine that LLLT contributes
to pain relief and increased function [27]. Subsequently,
findings from a number of trials on the effectiveness of
LLLT on shoulder disorders are not clear-cut. Both posi-
tive results [28,29] and no-effect results [30] exist for
studies targeting the benefits of LLLT. Although the
physiotherapy management of various shoulder com-
plaints is multifaceted, exercise therapy remains the main-
stay of treatment [8,31]. For ethical reasons, in studies that
evaluated the effect of LLLT, patients also received exer-
cise or other physiotherapeutic treatments in conjunction
with laser treatment [16,18,32-34]. It is therefore unclear
what specific contribution the LLLT had on shoulder pain,
range of motion and physical function. With this perspec-
tive, meta-analysis of low-level laser therapy in shoulder
disorders over placebo-only treatment would have been
appropriate save for the ethical considerations. However,
to meet the growing demand of health practitioners and
decision makers on evidence regarding LLLT, Green and
colleagues reported that evidence is very low on the effect-
iveness of LLLT on shoulder disorders [27]. The four pri-
mary studies reviewed by Green et al. [27], England et al.
[28], Saunders et al. [29], Vecchio et al. [30], and Tavena
[35] were fraught with methodological limitations. Since,
additional studies have examined the effectiveness of LLLT
on shoulder disorders [16-18,33,36-38]. Recently, one re-
view study [39] examined the effect of LLLT combined
with an exercise programme in adults with shoulder pain.
The authors did literature appraisal of four of the above
studies [16,32,33,37]. This study had several limitations:
there was no information on the assessment of risk of biasOutcomes
Elimination of oedema
se and catalase Reduction of lipid peroxidation
nd endorphin level growth Increase pain threshold
Defective epithelisation
Protein and collagen synthesis
and other cells Capillary formation
odifying cells
odifying cells.
Stimulation of physiological functions
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ity of findings. Moreover, the authors reported a qualita-
tive summary of individual studies to draw conclusions; a
meta-analysis of these studies would have provided a more
precise estimate of the effects of LLLT on shoulder pain
and function. In addition, undertaking subgroup and sen-
sitivity analyses could have impact on the conclusions. It
is therefore important and inevitable to conduct system-
atic reviews and meta-analysis of all these trials.
Objectives
The aim of this systematic review is to assess the effects
of low-level laser therapy with exercise compared to ex-
ercise alone in the treatment of shoulder disorders.
The secondary objective is to assess the safety of low-
level laser therapy in the treatment of shoulder disorders.
Methods/Design
Criteria for considering studies for this review
Types of studies
The review will consider randomised controlled trials
(RCTs).
Types of participants
The review will consider participants who are 18 years
and above, with a clinical or radiological diagnosis of
various shoulder pathologies by the referring ortho-
paedic surgeons and physiotherapist and receiving treat-
ments in both in- and outpatient physiotherapy clinics.
Types of interventions
The intervention group should have received exercise
therapy and either class IIIa (laser power output of less
than 5 mW) or IIIb (laser power output of less than
500 mW) LLLT at the site of pathology within the re-
quired range of laser treatment protocol for musculo-
skeletal injuries. The control group should have received
exercise therapy and placebo LLLT, and trials that do
not have control groups but used one shoulder as treat-
ment and opposite shoulder as a control will be ex-
cluded to avoid co-intervention of effect. Participants in
the eligible studies would have received LLLT as part of
treatment for included shoulder pathologies and infor-
mation on duration, intensity, dosage, frequency, treat-
ment time and accumulated energy delivered from all
sessions must be reported.
Types of outcome measures
The primary outcomes will be pain, disability and range
of motion related to shoulder injury.
 Pain measured by visual analogue scale (VAS) and
other categorical rating scales (the higher the rating,
the higher the pain). Disability: measures will include the different
validated instruments of disability (Shoulder Pain
and Disability Index, pain-free muscle strength,
6-minute maximal walking distance, Western
Ontario and McMasters Universities Osteoarthritis
Index, Roland Morris Disability Index, Oswestry
Pain and Disability Index). The mean (standard
deviation) disability scores will be used to pool
weighted mean differences (if one disability scale is
used in all the included studies). Where studies have
different scales to measure disability, standardised
mean differences (SMDs) will be used.
 Joint range of motion (passive and active).
The secondary outcome measures will include:
 Adverse effect measured by the number of patients
experiencing untoward reactions following LLLT
treatment.
 Other pain outcomes (for example pain measured at
rest, pain on palpation and during physical
activities).
 Quality of life measured by Short Form-36 (SF-36).
Search methods for identification of studies
Databases
To identify eligible RCTs for this review, an exhaustive
search of the following subject-specific databases will be
searched:
 Cochrane Central Register of Controlled Trials
(CENTRAL)
 MEDLINE (via EBSCOhost) (1996 to date)
 CINAHL (via EBSCOhost) (1996 to date)
 PEDro (Physiotherapy Evidence Database) (1997 to
date)
 Science Direct
 Scopus
 Physiotherapy Choices
There was no known information on when LLLT was
introduced as a treatment of choice in physiotherapy
practice. However, we commenced the search from 1996
because all the included studies in a previous and related
systematic review [27] were published on or before
1995. The search strategy for MEDLINE is detailed in
Additional file 1 and will be adapted for other databases.
Conference proceedings
We will search conference proceedings of World Associ-
ation for Laser Therapy to identify other relevant studies
for inclusion in this review. We will also send emails to all
the invited speakers, oral and poster speakers in the last
World Association for Laser Therapy 2012 Conference
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als relevant to this review.
Searching other resources
Hand searching of subject-specific journals: PhotoMedi-
cine and Laser Surgery (2007-2011), Lasers in Surgery
and Medicine (1996 to 2014) and Journals of Lasers in
Medical Science (2010 to present) will be checked manu-
ally to identify any other studies. Lastly, we will manu-
ally screen a reference list of included studies.
Data collection and analysis
Selection of studies
Two review authors (AD and GIJ) will independently
screen and select titles and abstracts of relevant trials.
Full texts of the articles will be obtained and assessed
for all potential eligible studies. These will be independ-
ently assessed to identify studies to be included in this
review based on a priori inclusion criteria. We will con-
tact the authors of primary studies if further information
is needed or some data are missing. We will resolve dis-
agreements on what studies to include in the review
through discussion, and should we fail to agree, a third
review author (TY) will be contacted to make the final
decision on disputed studies.
Data extraction and management
The two review authors (AD and GIJ) who will select
studies will independently extract the following informa-
tion from each included trial:
 Characteristics of the studies including source of
funding, country, setting, publication date, citation
and contact details.
 Participant characteristics including age, sex,
socio-demographics, diagnosis criteria, study
population.
 Characteristics of LLLT in both intervention and
control group, wavelength, class of laser, application
procedure, power density, energy dose delivered,
treatment time, number of sessions, frequency,
average output of laser reported, spot size on the
skin, power density and accumulated energy
delivered for all sessions.
 Outcome measures for dichotomous parameters, the
number of events will be extracted and means and
standard deviations for continuous outcomes for
estimating the effect of treatment.
Primary authors of the included studies will be con-
tacted if further information is needed and disagree-
ments between review authors will be resolved either
through discussion or consultation with a third reviewauthor (TY). Data will be captured in the table of in-
cluded studies.
Assessment of risk of bias in included studies
We will assess the risk of bias in included studies
independently against the following methodological
domains as recommended by the Cochrane Collabor-
ation [40]:
 Sequence generation
 Allocation sequence concealment
 Blinding of patients, health personnel and outcome
assessors
 Incomplete outcome data
 Selective outcome reporting
 Other biases
Each of these domains will be judged as: ‘low risk of
bias’, ‘high risk of bias’, or ‘uncertain’. We will resolve any
disagreement by discussion or arbitration through a
third review author.
Measurement of treatment effect
For continuous data (for example visual analogue pain
rating scale, shoulder disability assessed by validated in-
struments, shoulder range of motion, and Health-related
quality of life), we will calculate mean differences (MD)
with corresponding 95% confidence intervals. However,
we will use an SMD if different instruments were used
to measure the same outcome or construct. Where pos-
sible, if shoulder pain were assessed using a binary pain
rating scale (that is, pain vs. no pain), and adverse events
(number of the events in the treatment group vs. control
group), we will calculate risk ratios (RR) with corre-
sponding 95% confidence intervals.
Unit of analysis
The unit of analysis will be the patient.
Dealing with missing data
We will send an email to the respective trial author (s)
to obtain the missing data. We will neither make any as-
sumption nor will we perform imputations.
Assessment of heterogeneity
We will assess trials for clinical heterogeneity based on
patient characteristics, intervention characteristics, con-
trol group and outcome measures. For heterogeneity,
visual inspection of the forest plot, Chi square test and
I2 statistic will be performed. Both Chi2 test and I2 stat-
istic will be interpreted based on the guidelines recom-
mended by the Cochrane Handbook for Systematic
Review of Interventions [41]. The following values are
interpreted as thus:
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 p < 0.05 (strong likelihood of statistical
heterogeneity)
 p 0.05 < 0.1 (likely to be heterogeneous)
 p > 0.1 (not likely to be heterogeneous)
For I2 statistic:
 0%-40% (might not be important)
 30%-60% (moderately heterogeneous)
 50%-90% (substantial heterogeneity)
 75%-100% (considerable heterogeneity)
Assessment of reporting bias
We will assess the reporting bias using funnel plots if we
have at least ten studies from included studies that are
available for meta-analysis. Results of tests of visual in-
spection of the funnel plots will be interpreted on the basis
of other sources of asymmetry (that is heterogeneity).
Assessment of the quality of a body of evidence
We will use GRADE approach [42] to evaluate the qual-
ity of evidence for individual outcome reported in this
review against the following factors that may either in-
crease or decrease the quality of a body of evidence:
 Limitations in the design and implementation
 Indirectness of evidence
 Unexplained heterogeneity or inconsistency of
results
 Imprecision of results
 High probability of publication bias
 Presence of dose-response
Each individual outcome will be judged ‘High’, ‘Moderate’,
‘Low’ and ‘Very low’ levels of quality of a body evidence.
Data synthesis
The diagnostics of shoulder problem is often problem-
atic and clinical heterogeneity can be expected because
of variations in a population’s demographic characteris-
tics and applications of interventions between studies
(for example content, frequency, intensity). Therefore,
we would perform meta-analysis using random effects
model for estimates of intervention effects.
Assessment of safety of low-level laser therapy
We will describe the report of adverse effects or compli-
cations arising from the use of LLLT in included studies.
Subgroup analysis and investigation of heterogeneity
If there are substantial studies available for meta-analysis,
we will perform subgroup analyses using RevMan tocompare effect estimates to investigate whether LLLT
works differently in subset of participants (young partici-
pants vs. old participants: 18-35 years vs. >35 years), dur-
ation of intervention (short term: <3 months vs.
intermediate: 3-6 months vs. long term: >6 months) and
subsets of diagnosis (for example types of shoulder
disorder).
Sensitivity analysis
We will a perform sensitivity analysis to examine how
methodological criteria (allocation concealment and
blinding) affect the overall treatment effect. Specifically,
we will exclude studies that report high/unclear risk of
bias and see how it affects the overall treatment effect.
Discussion
To the best of the authors’ knowledge, there are no pub-
lished systematic reviews or meta-analysis that has spe-
cifically compared the effectiveness of low-laser therapy
with and without exercise of the following trials on
shoulder disorders (for example, an update from in-
cluded studies from 1996 onwards). Although the previ-
ous systematic review found low evidence for the benefit
of low-laser therapy in shoulder rehabilitation [27], we
hope the review of recent trials will shed more light on
the benefit of low-laser therapy as an adjunct treatment
to exercise in the management of shoulder disorders.
The findings may also inform decision makers in the re-
view and development of guidelines for shoulder re-
habilitation in physiotherapy practices.
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